Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Keyphrases
Mapk
100%
Immunomodulatory Properties
100%
ERK5
100%
Pharmacological Inhibitors
100%
Anticancer Therapy
100%
Endometrial Cancer
63%
Immunomodulatory Effect
27%
Anticancer Activity
27%
Immune Cells
27%
Immunodeficient Mice
18%
Cancer Tumor
18%
Immune Regulation
18%
Kinase Activity
18%
In Cancer
18%
Tumor
18%
ERK5 Kinase
18%
T Cells
18%
Cancer Patients
18%
Conventional Chemotherapy
9%
Recurrent Endometrial Cancer
9%
Oncogenic Signaling
9%
Pharmacokinetic Profile
9%
Types of Death
9%
Human Endometrial Cancer
9%
Protein Kinase Inhibitors
9%
Tumor Viability
9%
Tumor Proliferation
9%
Social Burden
9%
Endometrial Tumor
9%
Cancer Progression
9%
Specific Inhibitor
9%
Monotherapy
9%
Systemic Administration
9%
Regulatory Profiles
9%
Immunotherapeutics
9%
Metastatic Endometrial Cancer
9%
High-risk Endometrial Cancer
9%
Immune Checkpoint Inhibitors
9%
Recurrent or Metastatic
9%
Health Burden
9%
Dendritic Cells
9%
Lymphocytes T
9%
Western Countries
9%
Pharmacologic
9%
Immune Infiltration
9%
Clinical Efficacy
9%
Tumor Xenograft
9%
Immunogenic Cell Death
9%
Syngeneic Model
9%
Cytotoxic Effect
9%
Clinical Development
9%
Transgenic Mice
9%
Natural Killer Cells
9%
Tumor Antigen
9%
Cause of Death
9%
Cancer Cells
9%
New Therapies
9%
Targeted Therapy
9%
Cancer Cell Proliferation
9%
Economic Burden
9%
Current Treatment
9%
Molecular Mechanism
9%
Social Health
9%
Immune System
9%
Social Economics
9%
Medicine and Dentistry
Cancer Treatment
100%
Mitogen Activated Protein Kinase 7
100%
Mitogen-Activated Protein Kinase
100%
Uterine Cancer
76%
Malignant Neoplasm
30%
Immunotherapy
23%
Immunocompetent Cell
23%
Antineoplastic Activity
23%
Tumor
15%
Cancer Cell
15%
T Cell
15%
Phosphotransferase
15%
Cell Signaling Pathway
7%
Cell Proliferation
7%
Cytotoxicity
7%
Natural Killer Cell
7%
Tumor Xenograft
7%
Monotherapy
7%
Targeted Therapy
7%
Tumor Progression
7%
Systemic Administration
7%
Immune Cell Infiltration
7%
Cell Death
7%
Immunomodulating Agent
7%
Carcinogenesis
7%
Transgenic Mouse
7%
Immune Checkpoint Inhibitor
7%
Pharmacokinetics
7%
Social Health
7%
Tumor Antigen
7%
Immune System
7%
Endometrium Tumor
7%
Cancer Growth
7%
Lymphocyte
7%
Neoplasm
7%
Dendritic Cell
7%
Protein Kinase Inhibitor
7%
Immunology and Microbiology
Endometrium Cancer
100%
Uterine Cancer
100%
Immunocompetent Cell
30%
Immunotherapy
30%
Antineoplastic Activity
30%
Cancer Cell
30%
T Cell
20%
Xenograft
10%
Dendritic Cell
10%
Mouse Model
10%
Immune Cell Infiltration
10%
Natural Killer Cell
10%
Cell Death
10%
Tumor Antigen
10%
Transgenic Mouse
10%
Cytotoxicity
10%
Pharmacokinetics
10%
Immunomodulating Drugs
10%
Syngenic
10%
Lymphocyte
10%
Immune Checkpoint Inhibitor
10%
Immune System
10%